Cargando…
The role of immunotherapy for management of advanced thymic epithelial tumors: a narrative review
The emergence of immunotherapy as a modern pillar of cancer treatment has changed the treatment landscape for various cancers. Immune checkpoint inhibitors directed at programed death-1 (PD-1) or its ligand (PD-L1), in particular, have found widespread clinical applications and have resulted in dura...
Autores principales: | Rajan, Arun, Mullenix, Cristina, Shelat, Meenakshi, Zhao, Chen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8445513/ https://www.ncbi.nlm.nih.gov/pubmed/34541456 http://dx.doi.org/10.21037/med-20-62 |
Ejemplares similares
-
Tolerability of Coronavirus Disease 2019 Vaccines, BNT162b2 and mRNA-1273, in Patients With Thymic Epithelial Tumors
por: Ballman, Madison, et al.
Publicado: (2021) -
Immunotherapy for Management of Thymic Epithelial Tumors: A Double-Edged Sword
por: Ballman, Madison, et al.
Publicado: (2022) -
Deciphering the biology of thymic epithelial tumors
por: Rajan, Arun, et al.
Publicado: (2019) -
WT1 as an immunotherapy target for thymic epithelial tumors: a novel method to activate anti-tumor immunity
por: Takahashi, Nobuyuki, et al.
Publicado: (2019) -
Distinguishing between thymic carcinoma and lung carcinoma: a medical oncologist’s perspective
por: Rajan, Arun, et al.
Publicado: (2022)